Literature DB >> 25074635

A systematic review of the efficacy of prophylactic control measures for naturally-occurring canine leishmaniosis, part I: vaccinations.

C E Wylie1, M Carbonell-Antoñanzas2, E Aiassa3, S Dhollander3, F J Zagmutt4, D C Brodbelt5, L Solano-Gallego2.   

Abstract

Canine leishmaniosis (CanL) is an important zoonotic disease; however, the efficacy of available vaccines for the prevention of naturally-occurring Leishmania infantum (L. infantum) infection in dogs remains unclear. The objective of this review was to determine the efficacy of currently available vaccines to prevent naturally-occurring L. infantum infection in dogs. Four bibliographic databases (CAB Direct 2011, Web of Science 2011, U.S. National Library of Medicine 2011 and Literatura Latino Americana e do Caribe em Ciências da Saúde) were searched along with eight sets of conference proceedings and the International Veterinary Information Service (IVIS) database, from 1980 to November 2012. Randomised controlled trials (RCTs), non-randomised clinical trials (NRCTs), cohort studies and case-control studies that investigated vaccine efficacy for natural L. infantum infection in dogs were eligible for inclusion. Two review authors independently assessed each study against the inclusion criteria, independently extracted relevant data from all included studies and assessed the risk of methodological shortcomings in each individual study. The odds ratio (OR) and absolute risk reduction (ARR) for dichotomous outcomes and mean difference for continuous outcomes were calculated. Meta-analysis was not performed due to heterogeneity of the studies identified. The search was conducted for all mitigations for CanL and yielded the title and abstract of 937 articles, from which 84 articles were screened based on full text. Twelve studies on vaccinations (five RCTs, seven NRCTs) were identified. Ten studies were at a high risk of methodological shortcomings, whilst two were at an unclear risk. The use of 200 μg ALM protein, Leishmune(®), CaniLeish(®), LiESAp with MDP, and ALM with BCG tended to significantly reduce the proportion of dogs infected with L. infantum based on either parasitological or serological evidence. The use of lyophilized protein vaccine significantly increased the proportion of dogs infected with L. infantum based on either parasitological or serological evidence. There is peer-reviewed evidence that control measures are effective in preventing CanL with the results suggesting that between 6 and 54% of infections could be prevented with vaccination. However, this evidence is based on a small number of RCTs, all of which are either at high or unclear risk of methodological shortcomings. Well-designed, adequately powered and properly reported randomised clinical trials are needed to clearly establish efficacy of vaccines as CanL control measures.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Canine; Leishmania infantum; Leishmaniosis; Systematic review; Vaccination

Mesh:

Substances:

Year:  2014        PMID: 25074635     DOI: 10.1016/j.prevetmed.2014.06.015

Source DB:  PubMed          Journal:  Prev Vet Med        ISSN: 0167-5877            Impact factor:   2.670


  7 in total

Review 1.  Canine visceral leishmaniasis: Diagnosis and management of the reservoir living among us.

Authors:  Bruno L Travi; Anabela Cordeiro-da-Silva; Filipe Dantas-Torres; Guadalupe Miró
Journal:  PLoS Negl Trop Dis       Date:  2018-01-11

2.  Canine Leishmaniasis Control in the Context of One Health.

Authors:  Filipe Dantas-Torres; Guadalupe Miró; Gad Baneth; Patrick Bourdeau; Edward Breitschwerdt; Gioia Capelli; Luís Cardoso; Michael J Day; Gerhard Dobler; Luis Ferrer; Peter Irwin; Frans Jongejan; Volkhard A J Kempf; Barbara Kohn; Michael Lappin; Susan Little; Maxime Madder; Ricardo Maggi; Carla Maia; Mary Marcondes; Torsten Naucke; Gaetano Oliva; Maria Grazia Pennisi; Barend L Penzhorn; Andrew Peregrine; Martin Pfeffer; Xavier Roura; Angel Sainz; SungShik Shin; Laia Solano-Gallego; Reinhard K Straubinger; Séverine Tasker; Rebecca Traub; Ian Wright; Dwight D Bowman; Luigi Gradoni; Domenico Otranto
Journal:  Emerg Infect Dis       Date:  2019-12       Impact factor: 6.883

3.  Canine serological survey and dog culling ant its relationship with human visceral leishmaniasis in an endemic urban area.

Authors:  Patricia Marques Moralejo Bermudi; Danielle Nunes Carneiro Castro Costa; Caris Maroni Nunes; Jose Eduardo Tolezano; Roberto Mitsuyoshi Hiramoto; Lilian Aparecida Colebrusco Rodas; Rafael Silva Cipriano; Marta Blangiardo; Francisco Chiaravalloti-Neto
Journal:  BMC Infect Dis       Date:  2020-06-05       Impact factor: 3.090

4.  In-silico design of an immunoinformatics based multi-epitope vaccine against Leishmania donovani.

Authors:  Subhadip Saha; Shubham Vashishtha; Bishwajit Kundu; Monidipa Ghosh
Journal:  BMC Bioinformatics       Date:  2022-08-05       Impact factor: 3.307

Review 5.  Extracellular Vesicles: Role in Inflammatory Responses and Potential Uses in Vaccination in Cancer and Infectious Diseases.

Authors:  João Henrique Campos; Rodrigo Pedro Soares; Kleber Ribeiro; André Cronemberger Andrade; Wagner Luiz Batista; Ana Claudia Torrecilhas
Journal:  J Immunol Res       Date:  2015-08-25       Impact factor: 4.818

6.  Efficacies of prevention and control measures applied during an outbreak in Southwest Madrid, Spain.

Authors:  Anaiá da Paixão Sevá; Maia Martcheva; Necibe Tuncer; Isabella Fontana; Eugenia Carrillo; Javier Moreno; James Keesling
Journal:  PLoS One       Date:  2017-10-13       Impact factor: 3.240

Review 7.  Application of Dendrimers for Treating Parasitic Diseases.

Authors:  Veronica Folliero; Carla Zannella; Annalisa Chianese; Debora Stelitano; Annalisa Ambrosino; Anna De Filippis; Marilena Galdiero; Gianluigi Franci; Massimiliano Galdiero
Journal:  Pharmaceutics       Date:  2021-03-05       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.